-
Infographic – Covid-19 Brings Down Carbon Emissions
The chart shows double-digit percentage reductions in carbon dioxide emissions through 31 August for many countries experiencing high Covid-19 infection rates.
-
ALS Drug Shown to Extend Patient Survival
Results of a clinical trial show a drug to treat amyotrophic lateral sclerosis, or ALS, extends patients’ survival by several months and slows decline of their functions.
-
Q3 Venture Funds Inch Up, Early-Stage Deals Drop
Venture capital funding rose in the third quarter of 2020, driven in large part by investments in already established companies rather than newer enterprises.
-
Lilly Gains Neuro Disease Biotech in $1.36B Deal
Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders.
-
Maintaining Your Health Care in the New Normal
Science and technology can help families regain care of their general health and medical care in many ways.
-
Cancer Center, Biotech Partner on Off-the-Shelf T-Cells
MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells.
-
Blood Test Shown to Predict Covid-19 Symptom Severity
A blood test that measures the ratio of two key immune system proteins is shown in tests with patients to predict the severity of Covid-19 symptoms.
-
Gene Therapy Delivery Tech Licensed in $1.8B Deal
A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche.
-
Disaster-Proofing Your Business
Data breaches, compensation claims, and the competition are just three of the other issues that could hold disastrous repercussions for businesses.
-
NIH Trial Testing Current Drugs to Treat Covid-19
A clinical trial is planned to assess two drugs designed for other medical conditions as treatments for Covid-19 infections.